Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0001415889-25-006316

CHIEF EXECUTIVE OFFICER sold 5,690 shares at $2.35 ($13,372)

  • CHIEF EXECUTIVE OFFICER acquired 16,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lennon David James CHIEF EXECUTIVE OFFICER 2025-03-01 Option exercise +16,250 39,119 D
Lennon David James CHIEF EXECUTIVE OFFICER 2025-03-03 Sale −5,690 $2.35 $13,372 33,429 D
Derivatives
Lennon David James CHIEF EXECUTIVE OFFICER 2025-03-01 Option exercise · Restricted Stock Units −16,250 48,750 D
Open-market sales · 5,690 sh · avg $2.35 · $13,372
Loading xslF345X05/form4-03042025_010346.xml…